Abstract
In nuclear medicine, radiopharmaceuticals are administered to the patient either for the production of diagnostic images or with the intention to treat using the emitted radiation from the radiopharmaceutical. The increased use of PET-imaging causes a need for new planning of radiation protection. In radionuclide therapy, the activities are higher and the radionuclides used are often different from those used in diagnostic nuclear medicine and constitute a greater radiation protection problem. In both diagnostic and therapeutic nuclear medicine, the patient becomes a source of radiation not only for him/herself but also for staff, caregivers and the general public. All categories of staff members involved in nuclear medicine must have good knowledge of radiation protection. This is vital for patient safety as well as for the staff's own security, fore caregivers and the general public.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
International Commission on Radiological Protection (2007). The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 37(2–4)
Cantone MC, Hoeschen C (eds) (2011) Radiation physics for nuclear medicine. Springer, Heidelberg, pp 1–285
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mattsson, S. (2013). Introduction: The Importance of Radiation Protection in Nuclear Medicine. In: Mattsson, S., Hoeschen, C. (eds) Radiation Protection in Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31167-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-31167-3_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31166-6
Online ISBN: 978-3-642-31167-3
eBook Packages: MedicineMedicine (R0)